iNtRON Biotechnology, Inc. (KOSDAQ:048530)

iNtRON Biotechnology Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	124,458	102,745	183,560	291,422	269,879	709,999
Market Cap Growth	-2.70%	-44.03%	-37.01%	7.98%	-61.99%	-22.41%
Enterprise Value	86,037	67,818	129,604	224,880	175,332	642,575
Last Close Price	4060.00	3250.00	5610.00	8631.44	7899.18	20452.36
PE Ratio	-	-	-	-	47.25	72.99
PS Ratio	21.68	17.90	28.60	30.40	19.27	24.23
PB Ratio	1.78	1.47	2.19	3.01	2.54	7.01
P/TBV Ratio	1.81	1.49	2.23	3.06	2.58	7.09
P/FCF Ratio	-	-	-	-	72.00	52.88
P/OCF Ratio	-	-	-	93.48	45.15	43.10
EV/Sales Ratio	14.99	11.81	20.19	23.46	12.52	21.93
EV/EBITDA Ratio	-	-	-	-	1999.30	55.33
EV/EBIT Ratio	-	-	-	-	-	63.76
EV/FCF Ratio	-11.20	-	-	-	46.78	47.86
Debt / Equity Ratio	0.05	0.05	0.02	0.00	0.30	0.45
Debt / EBITDA Ratio	-	-	-	-	356.59	3.94
Debt / FCF Ratio	-	-	-	-	8.34	3.41
Net Debt / Equity Ratio	-0.55	-0.55	-0.58	-0.59	-0.73	-0.67
Net Debt / EBITDA Ratio	6.45	6.45	15.13	41.35	-878.94	-5.83
Net Debt / FCF Ratio	5.00	5.00	38.56	12.15	-20.56	-5.04
Asset Turnover	0.07	0.07	0.07	0.08	0.10	0.23
Inventory Turnover	2.74	2.74	2.57	4.20	4.89	6.01
Quick Ratio	10.46	10.46	37.96	76.13	3.50	3.73
Current Ratio	10.72	10.72	39.03	77.59	3.54	3.77
Return on Equity (ROE)	-11.66%	-11.66%	-2.87%	-9.56%	5.50%	10.42%
Return on Assets (ROA)	-6.15%	-6.15%	-3.54%	-1.71%	-0.63%	4.96%
Return on Invested Capital (ROIC)	-22.42%	-23.73%	-13.94%	-9.51%	-3.24%	29.38%
Return on Capital Employed (ROCE)	-11.30%	-11.30%	-6.20%	-3.40%	-1.40%	8.40%
Earnings Yield	-7.20%	-8.72%	-1.41%	-3.33%	2.12%	1.37%
FCF Yield	-6.17%	-7.47%	-0.69%	-1.60%	1.39%	1.89%
Buyback Yield / Dilution	3.49%	3.49%	1.18%	2.16%	-0.58%	4.41%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.